Clinical Trials Directory

Trials / Completed

CompletedNCT05268133

Aronia and Cognitive Fitness

Aronia and Cognitive Fitness: Focus on Brain Insulin-Sensitivity and Vascular Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
55 Years – 75 Years
Healthy volunteers
Accepted

Summary

Previously, beneficial effects of Aronia Melanocarpa extract (AME) supplementation on cognitive performance has been observed in healthy middle-aged adults. However, underlying mechanisms have not yet been addressed. In addition, effects of AME are unknown in subjects at increased risk of cognitive impairment. It is hypothesized that supplementation with AME enhances (regional) brain vascular function and brain insulin-sensitivity, thereby improving cognitive function of subjects at increased risk of cognitive impairment. The primary objectives are to investigate effects of AME intake on brain vascular function and insulin-sensitivity in cognitive-control brain areas, while we will also evaluate changes in cognitive function (secondary objective). The present study is a randomized, double-blind, placebo-controlled, cross-over trial consisting of two study groups and a pre- and post-test day in both study arms.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAroniaAs described in experimental arm
DIETARY_SUPPLEMENTControlAs described in placebo comparator arm

Timeline

Start date
2022-06-08
Primary completion
2023-08-25
Completion
2023-08-25
First posted
2022-03-07
Last updated
2025-09-24

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05268133. Inclusion in this directory is not an endorsement.